By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Announcement: How Gut Dysbiosis Triggers Systemic Inflammation: A Mechanistic Overview

Announcement: How Gut Dysbiosis Triggers Systemic Inflammation: A Mechanistic Overview

GMJ
Last updated: 13/08/2026 21:29
By
Prof. Giorgi Pkhakadze
Share
0 Min Read
Diagram showing pathways from dysbiosis through intestinal barrier dysfunction to systemic organ inflammation
When the gut microbiota becomes imbalanced, reduced production of short-chain fatty acids weakens the intestinal barrier, allowing bacterial toxins to enter the bloodstream and trigger systemic inflammation affecting metabolism, hormones, and multiple organ systems. — Photo by AI25.Studio Studio on Pexels (Pexels License)
SHARE
1 min read|44 words

When gut dysbiosis reduces beneficial bacteria, the intestinal barrier weakens—allowing bacterial toxins into the bloodstream and triggering systemic inflammation across adipose tissue, liver, pancreas, and brain. Explore the mechanistic pathway from dysbiosis to whole-body metabolic dysfunction.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: How Gut Dysbiosis Triggers Systemic Inflammation: A Mechanistic Overview →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK childhood vaccination coverage holds steady at high levels, latest quarterly data shows

The UK's Cover of Vaccination Evaluated Rapidly (COVER) programme reports sustained high…

EMA Launches Email Notifications for Clinical Trial Information System

The European Medicines Agency has rolled out email notification subscriptions in CTIS,…

Independent Inquiry Finds Systemic Racism in Maternity Care Undermines Patient Safety

An independent inquiry has documented systemic racism and discrimination affecting patient safety…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Pharmacy & PrescribingPolicy & SystemsPracticeQuality & Safety

FDA Issues Nationwide Recall of Adequan® Veterinary Products Due to Glass Contamination

By
Prof. Giorgi Pkhakadze
04/08/2026
FDA Vaccines and Related Biological Products Advisory Committee meeting room with advisers reviewing vaccine data

Takeaway: FDA Advisory Panel Endorses Moderna mRNA Flu Vaccine After Earlier Controversy

By
Prof. Giorgi Pkhakadze
12/08/2026
UK Health Security Agency Health Protection Report Volume 20 cover showing surveillance data trends

Two Decades of Continuous Surveillance: UKHSA’s Health Protection Report Marks Milestone

By
Prof. Giorgi Pkhakadze
22/07/2026

Ebola Outbreak in DRC’s North Kivu Province Poses Larger Public Health Risk, Africa CDC Official Warns

By
Prof. Giorgi Pkhakadze
17/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up